![Manish Potti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Manish Potti
Entité | Type d'entité | Industrie | |
---|---|---|---|
Solaris Pharma Corp.
![]() Solaris Pharma Corp. Pharmaceuticals: MajorHealth Technology Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Manish Potti via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
SiO2 Medical Products, Inc.
![]() SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL. | Medical Specialties | Director/Board Member Director/Board Member | |
Eon Labs, Inc.
![]() Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Palais Berlin 1 GmbH
![]() Palais Berlin 1 GmbH Real Estate DevelopmentFinance Palais Berlin 1 GmbH is a German company that specializes in the buying and selling of land, buildings, and flats. The private company is based in Munich, Germany. The CEOs of the company are Thomas Maier, Helmut Jeggle, Sebastian Breyer. | Real Estate Development | Chief Executive Officer | |
Horus Sentilo Projektentwicklungsgesellschaft mbH
![]() Horus Sentilo Projektentwicklungsgesellschaft mbH Investment ManagersFinance Horus Sentilo Projektentwicklungsgesellschaft mbH provides investment management services. The private company is based in Munich, Germany. The CEOs of the German company are Ulrich O. Fischer, Torsten Bischoff, Jürgen Böckeler. | Investment Managers | Chief Executive Officer | |
Salvia GmbH
![]() Salvia GmbH Investment ManagersFinance Salvia GmbH (Salvia) is a venture capital firm founded in 2014 by Helmut Jeggle. The firm is headquartered in Holzkirchen, Germany. | Investment Managers | Founder | |
Apceth Biopharma Manufacturing Co. Gmbh
![]() Apceth Biopharma Manufacturing Co. Gmbh Miscellaneous Commercial ServicesCommercial Services Apceth Biopharma Manufacturing Co. Gmbh is a German company that engages in research and development in natural sciences, engineering, agricultural sciences, and medicine. The private company is based in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
ATS Beteiligungsverwaltung GmbH
![]() ATS Beteiligungsverwaltung GmbH Investment ManagersFinance ATS Beteiligungsverwaltung GmbH (ATS Beteiligungsverwaltung) is an independent German private equity firm which is headquartered in Munich and was founded in 2006 by Andreas and Thomas Strüngmann, offering their know-how and strategic support to selected biotech companies. | Investment Managers | Private Equity Investor | |
Santo Holding (Deutschland) GmbH
![]() Santo Holding (Deutschland) GmbH Financial ConglomeratesFinance Santo Holding (Deutschland) GmbH operates as an investment holding company with focus on drug discovery and development. The company is based in Holzkirchen, Germany. | Financial Conglomerates | Chief Executive Officer | |
SWB Holding GmbH (Bayern)
![]() SWB Holding GmbH (Bayern) Financial ConglomeratesFinance SWB Holding GmbH is a German Munich-based company that was founded in 2013. The private company provides investment services. Thomas Peter Maier has been the CEO of the company since 2018. | Financial Conglomerates | Chief Executive Officer | |
Santo Service GmbH
![]() Santo Service GmbH Real Estate DevelopmentFinance Santo Service GmbH offers construction and management services for real estate. It holds interest in advising and financial management services. The company was founded on September 19, 2007 and is headquartered in Munich, Germany. | Real Estate Development | Chief Executive Officer | |
Jossa Arznei GmbH
![]() Jossa Arznei GmbH Pharmaceuticals: MajorHealth Technology Jossa Arznei GmbH engages in the manufacture and distribution of pharmaceutical products. It holds interest health care and medicine support services. The company was founded March 4, 1997 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Objektgesellschaft Berlin Passauer Straße 5-7 mbH
![]() Objektgesellschaft Berlin Passauer Straße 5-7 mbH Real Estate DevelopmentFinance Objektgesellschaft Berlin Passauer Straße 5-7 mbH is a company based in Munich, Germany. Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft Berlin Passauer Straße 5-7 mbH rents, leases, and owns land, buildings, and apartments. The German company was founded in 1997 and the CEOs are Helmut Jeggle and Thomas Peter Maier. | Real Estate Development | Chief Executive Officer | |
A&T Grundstück 1 GmbH
![]() A&T Grundstück 1 GmbH Real Estate DevelopmentFinance A & T Grundstück 1 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Thomas Maier, Sebastian Breyer, Helmut Jeggle. The company engages in buying and selling of commercial premises & non-residential buildings. | Real Estate Development | Chief Executive Officer | |
A&T Grundstück 2 GmbH
![]() A&T Grundstück 2 GmbH Real Estate DevelopmentFinance A & T Grundstück 2 GmbH is a private company based in Munich, Germany. The CEOs of the German company are Sebastian Breyer, Helmut Jeggle, Thomas Peter Maier. The company buys and sells land, buildings, and apartments. | Real Estate Development | Chief Executive Officer | |
Objektgesellschaft München Jahnstraße 41 und Klenzestraße
![]() Objektgesellschaft München Jahnstraße 41 und Klenzestraße Real Estate DevelopmentFinance Part of Münchener Rückversicherungs-Gesellschaft AG, Objektgesellschaft München Jahnstraße 41 und Klenzestraße is a residential property rental and leasing company based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Sebastian Breyer, Thomas Maier. The company rents and leases residential properties, buildings, and apartments. | Real Estate Development | Chief Executive Officer | |
ATHOS KG
![]() ATHOS KG Financial ConglomeratesFinance ATHOS KG is an investment holding German company founded in 2019. The company is based in Holzkirchen, Germany. | Financial Conglomerates | Chief Executive Officer | |
Klinge Pharma GmbH (Bayern)
![]() Klinge Pharma GmbH (Bayern) Pharmaceuticals: MajorHealth Technology Klinge Pharma GmbH is a pharmaceutical company based in Holzkirchen, Germany. Klinge Pharma's mission is to innovate and improve upon traditional pharmaceutical practices. The German company's description emphasizes their commitment to doing things better and their belief that innovation and tradition go hand in hand. The private company was founded in 1933 by A. Klinge and is currently led by CEOs Thomas Strüngmann, Fabian Strüngmann, and Ines Bohn. | Pharmaceuticals: Major | Chief Executive Officer | |
Aicuris Anti-Infective Cures AG
![]() Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chairman | |
IQM Finland Oy
![]() IQM Finland Oy Information Technology ServicesTechnology Services IQM Finland Oy operates as a quantum computing company. It engages in building hardware for quantum computers that focuses on superconducting technology. The company was founded by Juha Johannes Vartiainen, Kuan Yen Tan, Jan Goetz, and Mikko Pentti Matias M?tt?nen and is headquartered in Espoo, Finland. | Information Technology Services | Director/Board Member | |
LBG 2 GmbH
![]() LBG 2 GmbH Real Estate DevelopmentFinance LBG 2 GmbH provides residential real estate services. The private company is based in Munich, Germany. The CEOs of the German company are Helmut Jeggle, Thomas Maier. | Real Estate Development | Chief Executive Officer | |
TONIES SE | Recreational Products | Director/Board Member | |
ATB GmbH
![]() ATB GmbH Financial ConglomeratesFinance ATB GmbH is an investment holding German company founded in 2004. The private company is based in Gera, Germany. | Financial Conglomerates | Chief Executive Officer | |
Dr. Ernst Strüngmann Foundation gGmbH
![]() Dr. Ernst Strüngmann Foundation gGmbH Miscellaneous Commercial ServicesCommercial Services Dr. Ernst Strüngmann Foundation gGmbH is a biotechnology research and development company based in Munich, Germany. Dr. Ernst Strüngmann Foundation gGmbH engages in research and development on biotechnology. The German company was founded in 2007, and its CEOs are Andreas Strüngmann, Thomas Strüngmann, and Thomas Maier. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharma Radebeul GmbH
![]() Pharma Radebeul GmbH Finance/Rental/LeasingFinance Part of Jossa Arznei GmbH, Pharma Radebeul GmbH is a company that specializes in rentals and leases of industrial machinery. The company is based in Radebeul, Germany. Michael Riemenschneider has been the CEO of the German company since 2020. | Finance/Rental/Leasing | Chief Executive Officer | |
CorTec GmbH
![]() CorTec GmbH Medical SpecialtiesHealth Technology CorTec GmbH develops a neuro-technological platform for brain activity measurement and stimulation. The firm specializes in the designing a platform based on the CorTec Brain Interchange technology, with focus on opening up therapeutic and diagnostic possibilities. Its application areas encompass treatment, rehabilitation, and assistance technique. The firm also engages in research and development partnerships that deal with technology development programs and funding initiatives. The company was founded by Thomas Stieglitz, Wolfgang Meier, Christina Schwartz, Jorn Rickert, Markus Raab, Christian Henle, Martin Schuttler, and Jorg Fischer in September 2010 and is headquartered in Freiburg, Germany. | Medical Specialties | Director/Board Member | |
AiCuris GmbH & Co. KG
![]() AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
InnoPharma, Inc.
![]() InnoPharma, Inc. Pharmaceuticals: MajorHealth Technology InnoPharma, Inc. provides pharma drugs. The firm is a developer of sterile generic and specialty pharmaceutical products. It works with manufacturing and clinical research organizations worldwide for commercialization of its developed products. The company was founded by Navneet Puri and Sriram J. Ramanathan in 2005 and is headquartered in Piscataway, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nx Biotech GmbH | Chief Executive Officer | ||
APK AG
![]() APK AG Wholesale DistributorsDistribution Services APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany. | Wholesale Distributors | Director/Board Member | |
Minaris Regenerative Medicine GmbH
![]() Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
Fresenius Kabi Pharmaceuticals Holding LLC
![]() Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chairman | |
Chemwerth, Inc.
![]() Chemwerth, Inc. Pharmaceuticals: MajorHealth Technology Chemwerth, Inc. develops and supplies pharmaceutical products. The company offers oral, injectable, veterinary, oncology, topical, investigational stage, and in development stage products. It also offers a range of services, including regulatory affairs and technical service department, as well as customs clearance and logistics support services. The company was founded by Peter J. Werth Jr in 1982 and is headquartered in Woodbridge, CT. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | President | |
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Durachemie GmbH
![]() Durachemie GmbH Pharmaceuticals: OtherHealth Technology Part of Merck KGaA, Durachemie GmbH is a German company that specializes in medicinal chemicals and botanical products. The company is based in Wolfratshausen, Germany. Durachemie was acquired by Merck KGaA from Wyeth LLC on October 01, 1997. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Biotechnology | Chairman | |
Great Point Partners LLC
![]() Great Point Partners LLC Investment ManagersFinance Great Point Partners LLC (Great Point) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2003 by Dr. Jeffrey Jay and David Kroin. Great Point provides discretionary investment management services to pooled investment vehicles, which includes hedge funds and private equity funds, as well as separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
Softbox Systems Ltd.
![]() Softbox Systems Ltd. Industrial MachineryProducer Manufacturing Softbox Systems Ltd. provides temperature controlled packaging solutions for the biotechnology and pharmaceutical industries. It offers temperature control packaging design, temperature control shipper qualification, temperature control payload optimization and temperature control packaging training. The company was founded in 1995 and is headquartered in Long Crendon, the United Kingdom. | Industrial Machinery | Chairman | |
CAMBREX CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
BKH Pharma-Services | President | ||
Azalea TopCo, Inc.
![]() Azalea TopCo, Inc. Medical/Nursing ServicesHealth Services Azalea TopCo, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Softbox (Topco) Ltd.
![]() Softbox (Topco) Ltd. Industrial MachineryProducer Manufacturing Part of Softbox Holdings SARL, Softbox (Topco) Ltd. is a British company that provides world-class logistics support. The company was founded in 2014 and is based in Aylesbury, UK. Working with integrators, specialist couriers, and freight forwarding networks, Softbox's cold chain logistics experience has been a key consideration in their drive to create a complete range of high-performance temperature control packaging products for air, sea, and land. Softbox's innovative range of packaging systems, including the CSafe, has enabled them to become the first choice strategic packaging vendor to the pharmaceutical industry. The company's Softbox passive temperature control packaging solutions are trusted by leading pharmaceutical companies and specialist logistics providers. | Industrial Machinery | Director/Board Member | |
4SC AG | Biotechnology | Director/Board Member | |
APP Pharmaceuticals, Inc.
![]() APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chairman | |
BIONTECH SE | Biotechnology | Chairman |
Statistiques
Internationale
Allemagne | 33 |
Etats-Unis | 14 |
Royaume-Uni | 3 |
Finlande | 2 |
Luxembourg | 2 |
Sectorielle
Health Technology | 19 |
Finance | 18 |
Commercial Services | 6 |
Producer Manufacturing | 3 |
Technology Services | 2 |
Opérationnelle
Chief Executive Officer | 27 |
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Chairman | 7 |
President | 4 |
Relations les plus connectées
Insiders | |
---|---|
Helmut Jeggle | 47 |
Bernhard Hampl | 17 |
Satish Pejaver | 3 |
- Bourse
- Insiders
- Manish Potti
- Connexions Sociétés